⚡ 𝗛𝗜𝗠𝗦 & 𝗛𝗘𝗥𝗦-𝗡𝗢𝗩𝗢 𝗡𝗢𝗥𝗗𝗜𝗦𝗞 𝗖𝗢𝗟𝗟𝗔𝗕: 𝗧𝗛𝗘 𝗪𝗘𝗜𝗚𝗛𝗧 𝗟𝗢𝗦𝗦 𝗪𝗔𝗥𝗦 𝗚𝗢 𝗡𝗨𝗖𝗟𝗘𝗔𝗥 🔥 [kaley keto gummies]

⚡ 𝗛𝗜𝗠𝗦 & 𝗛𝗘𝗥𝗦-𝗡𝗢𝗩𝗢 𝗡𝗢𝗥𝗗𝗜𝗦𝗞 𝗖𝗢𝗟𝗟𝗔𝗕: 𝗧𝗛𝗘 𝗪𝗘𝗜𝗚𝗛𝗧 𝗟𝗢𝗦𝗦 𝗪𝗔𝗥𝗦 𝗚𝗢 𝗡𝗨𝗖𝗟𝗘𝗔𝗥 🔥 [kaley keto gummies]

| 1h 28m 28s | Video has closed captioning.

Hims & Hers just struck a major telehealth deal with Novo Nordisk to offer Wegovy for $599/month, opening a new high-margin revenue stream! But competition is fierce — Ro undercuts at $499, and Eli Lilly’s Zepbound (tirzepatide) shows superior results. In this video, we break down the implications for HIMS stock, Eli Lilly's FY25 guidance, and what investors should watch for on HIMS' May 5 earnings call. 📈 #HIMS #NovoNordisk #EliLilly #Wegovy #Zepbound #Telehealth #WeightLossDrugs #StockMarketNews #GrowthStocks #HealthTech #GLP1 #tirzepatide #semaglutide #HIMSS #Investing #PharmaStocks